As the tested compounds showed high activities on bcr-abl+ chronic myeloid leukemia cell lines BV-173, K-562, and AR-230, human cAbl tyrosine kinase was explored as a probable protein target. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.